- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.09. | Firefly Neuroscience und NeuroSigma kooperieren bei ADHS-Behandlung | 7 | Investing.com Deutsch | ||
| 25.09. | Firefly Neuroscience, Inc.: Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD | 4 | GlobeNewswire (USA) | ||
| 17.09. | Firefly Neuroscience, Inc.: Firefly Neuroscience's Evoke Platform Selected to Bring Objective Brain-Function Insights to Radial's AI-Native Operating System for Brain Medicine | 1 | GlobeNewswire (USA) | ||
| 07.08. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.08. | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes | 484 | GlobeNewswire (Europe) | KENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience... ► Artikel lesen | |
| 28.07. | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee's Recommendation Backs Broader Access to Key Neuroprotective Peptides | 1 | GlobeNewswire (USA) | ||
| FIREFLY NEUROSCIENCE Aktie jetzt für 0€ handeln | |||||
| 22.06. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.06. | Firefly Neuroscience identifies PTSD biomarker using AI | 3 | Investing.com | ||
| 02.06. | Firefly Neuroscience, Inc.: Firefly's AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD | 1 | GlobeNewswire (USA) | ||
| 20.05. | FIREFLY NEUROSCIENCE, INC. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| 13.05. | FIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.05. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.04. | Firefly Neuroscience sichert sich 8 Millionen US-Dollar durch weitere Privatplatzierung | 1 | Investing.com Deutsch | ||
| 22.04. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | - | SEC Filings | ||
| 13.04. | Firefly Neuroscience, Inc.: With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World's First Known 200,000+ Standardized EEG/ERP Depository | 7 | GlobeNewswire (USA) | ||
| 26.03. | Firefly Neuroscience, Inc.: Firefly Confirms Public-Private Partnership with the Department of War | 821 | GlobeNewswire (Europe) | Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service Members Partnership Represents a Significant Expansion of... ► Artikel lesen | |
| 13.03. | Firefly Neuroscience, Inc.: Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD | 594 | GlobeNewswire (Europe) | Over 22 million Americans are diagnosed with ADHD - yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1 Firefly's AI-powered EEG/ERP... ► Artikel lesen | |
| 12.11.25 | Firefly Neuroscience, Inc.: Firefly Neuroscience Reports Third Quarter 2025 Financial Results | 347 | GlobeNewswire (Europe) | - Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line - - Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP... ► Artikel lesen |
18 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 41,590 | -3,92 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius erwirbt verbleibende 45 % an mAbxience für bis zu 750 Mio. € und erhält vollständige Kontrolle über seine Biosimilars-Plattform | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Strategische Unternehmensentscheidung
Fresenius erwirbt verbleibende 45 % an mAbxience für bis zu 750 Mio. € und erhält vollständige... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,400 | -0,41 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ECKERT & ZIEGLER | 12,250 | +0,41 % | Eckert & Ziegler steigt - Berenberg sieht mehr Potenzial | ||
| UNITEDHEALTH | 328,80 | -2,08 % | UnitedHealthcare Unveils FY27 Medicare Advantage Plans | MINNETONKA (dpa-AFX) - Health care and well-being major UnitedHealth Group Inc. (UNH) Thursday introduced its 2027 Medicare Advantage plans, focused on affordability, simplicity and a more connected... ► Artikel lesen | |
| TELADOC HEALTH | 4,939 | -0,46 % | Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform | ||
| M1 AESTHETICS | 12,700 | -2,31 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| BECTON DICKINSON | 161,25 | +0,25 % | BD (Becton, Dickinson and Company): BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results | Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,074 | 0,00 % | Sernova Biotherapeutics, Inc.: Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial | TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. ("Seraxis") today announced... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 37,675 | +1,45 % | Boston Scientific Names Fitzgerald Executive Vice President & COO In New Operating Restructure | WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX), a medical technology company, on Wednesday announced that it has appointed Joseph M. Fitzgerald as Executive Vice President and Chief Operating... ► Artikel lesen | |
| CERENOME | 1,362 | +3,65 % | Cerenome, Inc.: Cerenome Launches CNSide CSF Molecular Profile Tests | HOUSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announced the commercial launch... ► Artikel lesen | |
| INMODE | 12,510 | 0,00 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,220 | +0,91 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| TANDEM DIABETES | 13,900 | -2,11 % | Tandem Diabetes Care, Inc.: Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets | Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,120 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen |
FIREFLY NEUROSCIENCE INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,010 (-0,83 %) liegt der Kurs bei 1,200 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FIREFLY NEUROSCIENCE INC finden Sie auf Wallstreet Online.